Pasil


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 26.8%
Pneumonia 10.4%
Pyrexia 7.7%
Systemic Mycosis 7.7%
Wound Complication 5.8%
Prophylaxis 5.0%
Constipation 3.7%
Infection 3.5%
Mycobacterium Avium Complex Infection 3.5%
Cerebral Infarction 3.1%
Nutritional Supplementation 3.1%
Convulsion Prophylaxis 2.9%
Meningitis 2.7%
Colon Cancer 2.3%
Immunosuppressant Drug Therapy 2.3%
Sepsis 2.3%
Cardiac Failure 1.9%
Fluid Replacement 1.7%
Hypertension 1.7%
Insomnia 1.7%
White Blood Cell Count Decreased 23.8%
Sepsis 11.9%
Rhabdomyolysis 9.5%
Pneumonia 7.1%
Cardiac Failure Acute 4.8%
Gastroenteritis 4.8%
Renal Failure 4.8%
Renal Failure Acute 4.8%
Sick Sinus Syndrome 4.8%
Sinus Tachycardia 4.8%
Stevens-johnson Syndrome 4.8%
Urinary Tract Infection 4.8%
Interstitial Lung Disease 2.4%
Jaundice 2.4%
Pneumonia Staphylococcal 2.4%
Renal Disorder 2.4%
Concomitant
Drug Use For Unknown Indication 17.8%
Product Used For Unknown Indication 15.9%
Pneumonia 9.2%
Multiple Myeloma 8.2%
Prophylaxis 7.1%
Infection 6.1%
Adult T-cell Lymphoma/leukaemia 4.5%
Hypertension 3.7%
Interstitial Lung Disease 3.7%
Insomnia 3.0%
Gastrointestinal Haemorrhage 2.7%
Febrile Neutropenia 2.6%
Neoplasm Malignant 2.6%
Constipation 2.2%
Pneumonia Aspiration 2.2%
Infection Prophylaxis 1.9%
Cancer Pain 1.7%
Myelodysplastic Syndrome 1.7%
Bronchopulmonary Aspergillosis 1.6%
Pulmonary Mycosis 1.6%
Interstitial Lung Disease 11.0%
White Blood Cell Count Decreased 11.0%
Platelet Count Decreased 7.7%
Renal Impairment 7.7%
Sepsis 7.7%
Refractoriness To Platelet Transfusion 6.6%
Tuberculosis 6.6%
Pneumonia 5.5%
Death 4.4%
Renal Disorder 4.4%
Septic Shock 4.4%
Cholangitis 3.3%
Pulmonary Fibrosis 3.3%
Thrombocytopenia 3.3%
Blood Pressure Decreased 2.2%
Hypoglycaemia 2.2%
Hypokalaemia 2.2%
Lung Disorder 2.2%
Pneumonia Staphylococcal 2.2%
Respiratory Failure 2.2%

Drug Data